Detection of spontaneous anti-neoepitope T-cell responses in non-metastatic bladder cancer patients

We show that one third of patients with non-metastatic bladder cancer mount a spontaneous and functional anti-neoepitope CD8<sup>+</sup> T-cell response detectable in blood or tumor. In 4 patients with NMIBC, BCG treatment did not boost or induce the anti-neoepitope response, suggesting alternative mechanisms of action for its efficacy.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-11-12
DOI
https://doi.org/10.3389/fimmu.2025.1627914
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Detection of spontaneous anti-neoepitope T-cell responses in non-metastatic bladder cancer patients

Hélène Dano, Bertrand F. TOMBAL, Beat Roth, Alexandre Harari et al.
Frontiers in Immunology
Bladder and Urothelial Cancer Treatments
article

Detection of spontaneous anti-neoepitope T-cell responses in non-metastatic bladder cancer patients

Hélène Dano, Bertrand F. TOMBAL, Beat Roth, Alexandre Harari, Audrey Masnada, Raphaël Genolet, Laurent Derré, Denise Nardelli‐Haefliger, Orian Bricard, Nicolas van Baren, Nicolas Dauguet, Gérald Hames, Walther Brochier, Sonia-Cristina Rodrigues-Dias, Sylvain Nguyen, Pierre G. Coulie, Valérie Cesson, Ilaria Lucca
article en

Abstract

We show that one third of patients with non-metastatic bladder cancer mount a spontaneous and functional anti-neoepitope CD8<sup>+</sup> T-cell response detectable in blood or tumor. In 4 patients with NMIBC, BCG treatment did not boost or induce the anti-neoepitope response, suggesting alternative mechanisms of action for its efficacy.

Frontiers in ImmunologyVol. 16
Cliniques Universitaires Saint-Luc (BE), University Hospital of Bern (CH), Ludwig Cancer Research (GB), de Duve Institute (BE), Ludwig Cancer Research (CH), University of Lausanne (CH)
National Science Foundation, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Université de Lausanne, Centre Hospitalier Universitaire Vaudois, Walloon excellence in life sciences and biotechnology
Openalex Percentile: Top 48%
Bladder and Urothelial Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.